达嘉维康：拟收购安徽达嘉维康健康大药房有限公司60.85%股权

Group 1 - The company plans to acquire 60.85% equity of Anhui Dajia Weikang Health Pharmacy Co., Ltd. for a transaction price of 115.615 million yuan [1] - Upon completion of the transaction, Anhui Dajia Weikang will become a subsidiary of the company and will be included in the company's consolidated financial statements [1] - The transaction constitutes a related party transaction, and the company's board of directors has approved the proposal, authorizing the chairman to sign relevant contract documents [1]